Abbot
A USA company, Abbott, has received authorization from the U.S. Food and Drug Administration for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes.
What makes this test so different is where it can be used: outside the four walls of a traditional hospital such as in the physicians’ office or urgent care clinics.
The test runs on a lightweight box (6.6 pounds and the size of a small toaster) that can sit in a variety of locations.
Because of its small size, it can be used in more non-traditional places where people can have their results in a matter of minutes.
They are ramping up production to deliver 50,000 ID NOW COVID-19 tests per day, beginning next week, to the U.S. healthcare system.
“Through the incredible work of teams across Abbott, we expect to deliver 50,000 COVID-19 tests per day to healthcare professionals on the front lines, where testing capabilities are needed most,” said Chris Scoggins, senior vice president, Rapid Diagnostics, Abbott.
You may be interested
2024 CHANQ: History Not Kind To Us Against Ghana –Ogunmodede
Webby - December 24, 2024Home-based Super Eagles coach Daniel Ogunmodede says history has not been good to Nigeria when they face rivals Ghana.The home-based…
Ex-Chelsea Star Oscar Returns To Boyhood Club Sao Paulo
Webby - December 24, 2024Former Chelsea midfielder Oscar is returning to his Brazilian boyhood club Sao Paulo after 14 years, which included a long…
‘I’m Incredibly Proud’– Arokodare Talks Up Genk’s Unbeaten Home Streak
Webby - December 23, 2024Tolu Arokodare is full of excitement followingGenk’s historic victory over Anderlecht, reports Completesports.com.Sunday’s win at the Cegeka Arena was the…